-
Catalyst Pharmaceuticals Inc. (CPRX $20.59)
- $20.59 P/E (TTM): 12.48X Cap: $2.52B
- View CPRX Profile
- View Questions on CPRX
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Catalyst Pharmaceuticals Inc. (CPRX $20.59)
- $20.59 P/E (TTM): 12.48X Cap: $2.52B
- View CPRX Profile
- View Questions on CPRX
Q: Are there any news or downgrades for CPRX? It's down 3.5% on the up day. Do you still like/recommend this stock for healthcare holdings?
-
Catalyst Pharmaceuticals Inc. (CPRX $20.59)
- $20.59 P/E (TTM): 12.48X Cap: $2.52B
- View CPRX Profile
- View Questions on CPRX
Q: Hi 5i Team,
Pls comment on Catalyst Pharmaceuticals quarter earning and this company going forward.
Thanks .
Pls comment on Catalyst Pharmaceuticals quarter earning and this company going forward.
Thanks .
-
Gilead Sciences Inc. (GILD $112.97)
- $112.97 P/E (TTM): 23.73X Cap: $140.17B
- View GILD Profile
- View Questions on GILD
-
Intuitive Surgical Inc. (ISRG $473.30)
- $473.30 P/E (TTM): 65.92X Cap: $169.66B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $210.40)
- $210.40 P/E (TTM): 89.91X Cap: $371.68B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $177.17)
- $177.17 P/E (TTM): 18.95X Cap: $426.68B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $732.58)
- $732.58 P/E (TTM): 59.61X Cap: $693.35B
- View LLY Profile
- View Questions on LLY
-
Medtronic plc. (MDT $92.81)
- $92.81 P/E (TTM): 25.71X Cap: $119.04B
- View MDT Profile
- View Questions on MDT
-
Stryker Corporation (SYK $391.41)
- $391.41 P/E (TTM): 51.84X Cap: $149.63B
- View SYK Profile
- View Questions on SYK
-
Thermo Fisher Scientific Inc (TMO $492.72)
- $492.72 P/E (TTM): 28.5X Cap: $186.05B
- View TMO Profile
- View Questions on TMO
-
Health Care Select Sector SPDR (XLV $137.43)
- $137.43 P/E (TTM): 83.99X Cap: $33.58B
- View XLV Profile
- View Questions on XLV
-
iShares U.S. Medical Devices ETF (IHI $62.15)
- $62.15 P/E (TTM): 164.7X Cap: $4.32B
- View IHI Profile
- View Questions on IHI
-
Sabra Health Care REIT Inc. (SBRA $19.11)
- $19.11 P/E (TTM): 31.85X Cap: $4.58B
- View SBRA Profile
- View Questions on SBRA
-
Healthcare Realty Trust Incorporated (HR $17.38)
- $17.38 Cap: $6.11B
- View HR Profile
- View Questions on HR
-
iShares U.S. Pharmaceuticals ETF (IHE $71.16)
- $71.16 P/E (TTM): 63.66X Cap: $583M
- View IHE Profile
- View Questions on IHE
-
Catalyst Pharmaceuticals Inc. (CPRX $20.59)
- $20.59 P/E (TTM): 12.48X Cap: $2.52B
- View CPRX Profile
- View Questions on CPRX
Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.
Insiders
Share Information
SEC Filings
News and Media